September 16, 2025 11:45 ET | Source: Transgene S.A. Transgene S.A.
RAPPORT SEMESTRIEL 2025
Pièce jointe
Transgene to Participate in Upcoming Investor Meetings
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
